MetLife Investment Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9K | Sell |
4,326
-299
| -6% | -$2.89K | ﹤0.01% | 2692 |
|
|
2025
Q1 | $68.9K | Buy |
4,625
+106
| +2% | +$1.58K | ﹤0.01% | 2651 |
|
|
2024
Q4 | $67.4K | Buy |
4,519
+13
| +0.3% | +$194 | ﹤0.01% | 2711 |
|
|
2024
Q3 | $86.2K | Sell |
4,506
-102
| -2% | -$1.95K | ﹤0.01% | 2682 |
|
|
2024
Q2 | $95.4K | Sell |
4,608
-374
| -8% | -$7.74K | ﹤0.01% | 2630 |
|
|
2024
Q1 | $93.7K | Buy |
4,982
+12
| +0.2% | +$226 | ﹤0.01% | 2565 |
|
|
2023
Q4 | $71.7K | Sell |
4,970
-58,236
| -92% | -$840K | ﹤0.01% | 2732 |
|
|
2023
Q3 | $1.1M | Sell |
63,206
-1,534
| -2% | -$26.6K | 0.01% | 1181 |
|
|
2023
Q2 | $1.35M | Sell |
64,740
-893
| -1% | -$18.6K | 0.01% | 1109 |
|
|
2023
Q1 | $1.54M | Sell |
65,633
-788
| -1% | -$18.5K | 0.01% | 1010 |
|
|
2022
Q4 | $1.86M | Sell |
66,421
-1,077
| -2% | -$30.1K | 0.01% | 935 |
|
|
2022
Q3 | $1.58M | Sell |
67,498
-836
| -1% | -$19.6K | 0.01% | 980 |
|
|
2022
Q2 | $2.31M | Sell |
68,334
-653
| -0.9% | -$22K | 0.02% | 846 |
|
|
2022
Q1 | $2.41M | Buy |
68,987
+12,969
| +23% | +$453K | 0.02% | 923 |
|
|
2021
Q4 | $1.71M | Sell |
56,018
-1,241
| -2% | -$37.8K | 0.01% | 923 |
|
|
2021
Q3 | $1.88M | Sell |
57,259
-1,404
| -2% | -$46K | 0.02% | 884 |
|
|
2021
Q2 | $1.78M | Buy |
+58,663
| New | +$1.78M | 0.02% | 923 |
|